{
  "id": 106788,
  "name": "AKEBIA THERAPEUTICS, INC.",
  "slug": "akebia-therapeutics-inc",
  "state": "MA",
  "description": "Biopharmaceutical company",
  "totalSpending": 1390000,
  "filings": 25,
  "yearlySpending": [
    {
      "year": 2019,
      "income": 60000
    },
    {
      "year": 2020,
      "income": 240000
    },
    {
      "year": 2021,
      "income": 300000
    },
    {
      "year": 2022,
      "income": 240000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 200000
    },
    {
      "year": 2025,
      "income": 150000
    }
  ],
  "firms": [
    "BGR GOVERNMENT AFFAIRS"
  ],
  "lobbyists": [
    "ROBERT WOOD",
    "BRENT DEL MONTE",
    "ROBB WALTON",
    "MATT HOFFMANN",
    "JOHN STONE",
    "DANIEL FARMER",
    "ANDREW LEWIN",
    "CACHAVIOUS ENGLISH",
    "JOEL BAILEY",
    "CHRIS KELLY"
  ],
  "issues": [
    "HCR",
    null
  ],
  "sampleDescriptions": [
    "Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry.",
    "Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and HR 8177 - RAISE Act.",
    "Provide strategic guidance and counsel on issues impacting the biopharmaceutical industry and legislation to provide greater access to kidney care."
  ],
  "years": [
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 150,
  "trajectory": "exploding",
  "yearsActive": 7,
  "avgAnnualSpending": 198571,
  "peakYear": 2021,
  "lobbyistCount": 10,
  "firmCount": 1,
  "issueCount": 1
}